[Effect of oligoribonucleotides specifically bound by E. coli RNA-polymerase on DNA-dependent RNA synthesis]. 1976

V L Knorre, and I Iu Efimova, and R I Salganik

It was shown previously that E. coli RNA-polymerase (EC 2.7.7.6) selectively binds certain fractions of penta- or hexaribonucleotides random mixtures (Knorre V. L., Vasilenko S. V., Salganik R. I., FEBS Lett., 30, 229, 1973). The data obtained demonstrate that such oligoribonucleotides compete with DNA for the RNA polymerase active centre and inhibit DNA dependent RNA synthesis catalyzed by the enzyme. These properties are absent in tri- and tetraribonucleotides which cannot be bound by RNA polymerase. The inhibitory action of the pentaribonucleotides was higher when they had been added prior to DNA to the mixture containing RNA polymerase.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009841 Oligonucleotides Polymers made up of a few (2-20) nucleotides. In molecular genetics, they refer to a short sequence synthesized to match a region where a mutation is known to occur, and then used as a probe (OLIGONUCLEOTIDE PROBES). (Dorland, 28th ed) Oligonucleotide
D009843 Oligoribonucleotides A group of ribonucleotides (up to 12) in which the phosphate residues of each ribonucleotide act as bridges in forming diester linkages between the ribose moieties.
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D012321 DNA-Directed RNA Polymerases Enzymes that catalyze DNA template-directed extension of the 3'-end of an RNA strand one nucleotide at a time. They can initiate a chain de novo. In eukaryotes, three forms of the enzyme have been distinguished on the basis of sensitivity to alpha-amanitin, and the type of RNA synthesized. (From Enzyme Nomenclature, 1992). DNA-Dependent RNA Polymerases,RNA Polymerases,Transcriptases,DNA-Directed RNA Polymerase,RNA Polymerase,Transcriptase,DNA Dependent RNA Polymerases,DNA Directed RNA Polymerase,DNA Directed RNA Polymerases,Polymerase, DNA-Directed RNA,Polymerase, RNA,Polymerases, DNA-Dependent RNA,Polymerases, DNA-Directed RNA,Polymerases, RNA,RNA Polymerase, DNA-Directed,RNA Polymerases, DNA-Dependent,RNA Polymerases, DNA-Directed
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

V L Knorre, and I Iu Efimova, and R I Salganik
July 1971, Nature,
V L Knorre, and I Iu Efimova, and R I Salganik
July 1975, Biochemical and biophysical research communications,
V L Knorre, and I Iu Efimova, and R I Salganik
April 1973, Biochemical and biophysical research communications,
V L Knorre, and I Iu Efimova, and R I Salganik
December 1967, European journal of biochemistry,
V L Knorre, and I Iu Efimova, and R I Salganik
August 1972, Biochemical and biophysical research communications,
V L Knorre, and I Iu Efimova, and R I Salganik
April 1970, FEBS letters,
V L Knorre, and I Iu Efimova, and R I Salganik
September 1981, Current genetics,
V L Knorre, and I Iu Efimova, and R I Salganik
November 1977, Chemical & pharmaceutical bulletin,
V L Knorre, and I Iu Efimova, and R I Salganik
July 1971, Journal of biochemistry,
Copied contents to your clipboard!